Mason Street Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-13,767
Closed -$854K 699
2020
Q4
$854K Sell
13,767
-27
-0.2% -$1.68K 0.01% 1000
2020
Q3
$820K Sell
13,794
-304
-2% -$18.1K 0.02% 903
2020
Q2
$984K Buy
14,098
+25
+0.2% +$1.75K 0.02% 825
2020
Q1
$638K Sell
14,073
-902
-6% -$40.9K 0.01% 899
2019
Q4
$974K Sell
14,975
-1,007
-6% -$65.5K 0.02% 894
2019
Q3
$992K Sell
15,982
-763
-5% -$47.4K 0.02% 854
2019
Q2
$1.19M Sell
16,745
-683
-4% -$48.6K 0.02% 789
2019
Q1
$1.37M Sell
17,428
-418
-2% -$32.8K 0.03% 768
2018
Q4
$1.51M Buy
17,846
+7,822
+78% +$662K 0.04% 624
2018
Q3
$1.72M Buy
10,024
+154
+2% +$26.4K 0.04% 657
2018
Q2
$1.28M Buy
9,870
+484
+5% +$62.6K 0.03% 786
2018
Q1
$967K Buy
9,386
+587
+7% +$60.5K 0.02% 849
2017
Q4
$752K Buy
8,799
+306
+4% +$26.2K 0.02% 920
2017
Q3
$721K Buy
8,493
+967
+13% +$82.1K 0.02% 922
2017
Q2
$570K Buy
7,526
+412
+6% +$31.2K 0.01% 965
2017
Q1
$470K Buy
7,114
+452
+7% +$29.9K 0.01% 1005
2016
Q4
$422K Buy
6,662
+399
+6% +$25.3K 0.01% 1012
2016
Q3
$399K Buy
6,263
+325
+5% +$20.7K 0.01% 997
2016
Q2
$442K Buy
5,938
+772
+15% +$57.5K 0.01% 938
2016
Q1
$345K Buy
5,166
+480
+10% +$32.1K 0.01% 974
2015
Q4
$317K Buy
4,686
+419
+10% +$28.3K 0.01% 967
2015
Q3
$228K Buy
4,267
+304
+8% +$16.2K 0.01% 1036
2015
Q2
$249K Buy
3,963
+170
+4% +$10.7K 0.01% 1017
2015
Q1
$182K Buy
3,793
+36
+1% +$1.73K 0.01% 1114
2014
Q4
$125K Sell
3,757
-26
-0.7% -$865 ﹤0.01% 1633
2014
Q3
$111K Sell
3,783
-393
-9% -$11.5K ﹤0.01% 1646
2014
Q2
$162K Buy
4,176
+141
+3% +$5.47K ﹤0.01% 1528
2014
Q1
$169K Sell
4,035
-1,168
-22% -$48.9K ﹤0.01% 1489
2013
Q4
$171K Buy
+5,203
New +$171K ﹤0.01% 1556